Matches in Nanopublications for { ?s ?p "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP273073.RAbogMHsUtPhU6FFOFYZ2HbcPEP6R-Ga-mrUGniDLRUTU130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273073.RAbogMHsUtPhU6FFOFYZ2HbcPEP6R-Ga-mrUGniDLRUTU130_provenance.
- NP44946.RAx0uGof2WH4Tl9LS1CNv8DNV0RZnuajbcd-VSJwrsFgA130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP44946.RAx0uGof2WH4Tl9LS1CNv8DNV0RZnuajbcd-VSJwrsFgA130_provenance.
- NP62072.RAbhEalJ6vyIq-KFo2SQVWZdUpdLI0cpgZU6BIzRYPp8c130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62072.RAbhEalJ6vyIq-KFo2SQVWZdUpdLI0cpgZU6BIzRYPp8c130_provenance.
- assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381642.RAfr__2FZgEFYG0R3hoLCeTEwnYtLgYtbVxMaDHG9yHWg130_provenance.
- NP771132.RACW7PCnwUnotryNQ7kxvDq35UO4yxBzczVxthXVZwdpQ130_assertion description "[The purpose of the present study was to investigate polymorphisms related to the metabolism of fluoropyrimidine and oxaliplatin, thymidylate synthase (TS) and excision repair cross-complementing gene 1 (ERCC1) 118, in metastatic colorectal cancer patients treated with capecitabine and oxaliplatin (XELOX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771132.RACW7PCnwUnotryNQ7kxvDq35UO4yxBzczVxthXVZwdpQ130_provenance.